✦ LIBER ✦

Anti-CD20 monoclonal antibody 131I-C2B8 beneficial in NHL

Book ID: 120863744
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213430-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-CD20 monoclonal antibody C2B8-I-131

✍ Torresilla, Cynthia; Do Carmo, Sonia; Larocque, Émilie; Douceron, Estelle; Mesna 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB

Anti-CD45 monoclonal antibody BC8-I-131

Anti-CD45 monoclonal antibody BC8-I-131 promising in leukaemia

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 342 KB

Growth Inhibition of CD20-positive B Lym

Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody

✍ Taji, Hirohumi ;Kagami, Yoshitoyo ;Okada, Yasutaka ;Andou, Manabu ;Nishi, Yoshim 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 469 KB

Anti-CD20 monoclonal antibody therapy in

Anti-CD20 monoclonal antibody therapy in multiple myeloma

✍ Prashant Kapoor; Patricia T. Greipp; William G. Morice; S. Vincent Rajkumar; Tho 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Immunotherapy of relapsed B-cell lymphom

Immunotherapy of relapsed B-cell lymphoma with an anti-CD20 antibody (IDEC-C2B8)

✍ A.J. Grillo-López 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Biodistribution and kinetics of131I-labe

Biodistribution and kinetics of131I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma

✍ Schmidt, Burkhard; Reidel, Günther; Peschel, Christian; Schwaiger, Marku 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 63 KB